Kenneth T. Mills, President and CEO at REGENXBIO Inc. (RGNX), sold 3,000 shares at $40.77 ($122K) on 2021-02-25, disclosed to the SEC on 2021-03-01.
Open-market sale of $122k RGNX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.77 | 1,500 | $61K | 50.0% |
| 2 | $40.77 | 1,500 | $61K | 50.0% |
| Total | $40.77 avg | 3,000 | $122K | 100% |
| Filing → |
| RGNX | SELL | 2024-07-18 | $33K | — | Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |